BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 102 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,762,073 | +8.9% | 16,774,304 | +8.3% | 0.00% | 0.0% |
| Q2 2023 | $109,089,750 | -11.8% | 15,495,703 | +4.5% | 0.00% | -25.0% |
| Q1 2023 | $123,638,815 | -27.8% | 14,824,798 | -0.6% | 0.00% | -20.0% |
| Q4 2022 | $171,269,603 | -1.3% | 14,918,955 | +8.3% | 0.01% | -16.7% |
| Q3 2022 | $173,565,000 | +17.3% | 13,774,995 | -1.5% | 0.01% | +20.0% |
| Q2 2022 | $147,984,000 | -35.5% | 13,987,418 | -0.8% | 0.01% | -16.7% |
| Q1 2022 | $229,298,000 | +12.0% | 14,101,975 | -4.6% | 0.01% | +20.0% |
| Q4 2021 | $204,805,000 | -7.0% | 14,787,395 | -3.5% | 0.01% | -16.7% |
| Q3 2021 | $220,303,000 | -10.0% | 15,330,858 | -1.0% | 0.01% | -14.3% |
| Q2 2021 | $244,759,000 | +48.2% | 15,481,327 | -4.7% | 0.01% | +40.0% |
| Q1 2021 | $165,180,000 | +36.4% | 16,241,775 | -0.1% | 0.01% | +25.0% |
| Q4 2020 | $121,134,000 | +121.2% | 16,259,745 | +2.0% | 0.00% | +100.0% |
| Q3 2020 | $54,766,000 | -21.6% | 15,943,893 | +8.7% | 0.00% | -33.3% |
| Q2 2020 | $69,887,000 | +160.9% | 14,666,914 | +9.5% | 0.00% | +200.0% |
| Q1 2020 | $26,790,000 | -36.1% | 13,395,617 | +10.3% | 0.00% | -50.0% |
| Q4 2019 | $41,918,000 | +52.5% | 12,150,211 | +26.6% | 0.00% | +100.0% |
| Q3 2019 | $27,489,000 | -18.7% | 9,594,780 | +7.5% | 0.00% | 0.0% |
| Q2 2019 | $33,831,000 | -52.2% | 8,925,891 | +2.6% | 0.00% | -66.7% |
| Q1 2019 | $70,796,000 | -0.9% | 8,697,366 | -1.7% | 0.00% | -25.0% |
| Q4 2018 | $71,413,000 | +6.7% | 8,849,427 | +0.9% | 0.00% | +33.3% |
| Q3 2018 | $66,914,000 | +50.6% | 8,769,856 | +13.1% | 0.00% | +50.0% |
| Q2 2018 | $44,442,000 | +24.7% | 7,755,951 | +3.8% | 0.00% | 0.0% |
| Q1 2018 | $35,653,000 | -4.6% | 7,474,419 | -1.8% | 0.00% | 0.0% |
| Q4 2017 | $37,386,000 | +7.8% | 7,614,280 | +15.0% | 0.00% | 0.0% |
| Q3 2017 | $34,696,000 | -0.3% | 6,621,180 | +5.8% | 0.00% | 0.0% |
| Q2 2017 | $34,796,000 | -31.1% | 6,258,377 | +4.1% | 0.00% | -33.3% |
| Q1 2017 | $50,520,000 | +77623.1% | 6,014,277 | +58823.1% | 0.00% | – |
| Q4 2016 | $65,000 | +47.7% | 10,207 | +2.3% | 0.00% | – |
| Q3 2016 | $44,000 | -8.3% | 9,976 | -40.2% | 0.00% | – |
| Q2 2016 | $48,000 | +242.9% | 16,675 | +248.0% | 0.00% | – |
| Q1 2016 | $14,000 | -33.3% | 4,792 | +136.9% | 0.00% | – |
| Q4 2015 | $21,000 | +23.5% | 2,023 | +37.4% | 0.00% | – |
| Q3 2015 | $17,000 | -98.1% | 1,472 | -97.6% | 0.00% | -100.0% |
| Q2 2015 | $900,000 | +56.5% | 60,272 | -5.3% | 0.00% | 0.0% |
| Q1 2015 | $575,000 | -25.7% | 63,617 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $774,000 | +24.4% | 63,617 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $622,000 | -28.2% | 63,617 | -6.3% | 0.00% | 0.0% |
| Q2 2014 | $866,000 | – | 67,917 | +485021.4% | 0.00% | – |
| Q1 2014 | $0 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |